Karl Kelley
Technik-/Wissenschafts-/F&E-Leiter bei RAIsonance, Inc.
Profil
Karl D.
Kelley currently works as a Director & Chief Medical Officer at RAIsonance, Inc.
Aktive Positionen von Karl Kelley
| Unternehmen | Position | Beginn |
|---|---|---|
RAIsonance, Inc.
 RAIsonance, Inc. Information Technology ServicesTechnology Services RAIsonance, Inc. is a family of companies based in the Denver Tech Center that specializes in artificial intelligence/machine learning-based healthcare solutions. The American company operates wellness products such as MyAdvocate and Biometric SoundPass for consumers, and the workforce wellness solution FCV Sentinel for the enterprise. Additionally, RAIsonance is developing diagnostic solutions for COVID-19, influenza, tuberculosis, and RSV. Originally funded with a grant from the National Science Foundation, RAIsonance has developed breakthrough technology innovations that use signal data signature recognition as a biomarker for human medical diagnostics and to support ground-breaking safety applications. The company was founded in 2020 by Catherine M. Kolding, who has been the CEO since then. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
RAIsonance, Inc.
RAIsonance, Inc. Information Technology ServicesTechnology Services RAIsonance, Inc. is a family of companies based in the Denver Tech Center that specializes in artificial intelligence/machine learning-based healthcare solutions. The American company operates wellness products such as MyAdvocate and Biometric SoundPass for consumers, and the workforce wellness solution FCV Sentinel for the enterprise. Additionally, RAIsonance is developing diagnostic solutions for COVID-19, influenza, tuberculosis, and RSV. Originally funded with a grant from the National Science Foundation, RAIsonance has developed breakthrough technology innovations that use signal data signature recognition as a biomarker for human medical diagnostics and to support ground-breaking safety applications. The company was founded in 2020 by Catherine M. Kolding, who has been the CEO since then. | Technology Services |
